Cita APA

El-Khoueiry, A. (., Trojan, J. (., Meyer, T. (., Yau, T. (., Melero, I. (., Kudo, M. (., . . . Sangro-Gómez-Acebo, B. (. C. (2023). Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040.

Citación estilo Chicago

El-Khoueiry, A. (Anthony)|||/items/8144acbd-0107-4f48-8776-9e28947910d4, et al. Nivolumab in Sorafenib-naive and Sorafenib-experienced Patients With Advanced Hepatocellular Carcinoma: 5-year Follow-up From CheckMate 040. 2023.

Cita MLA

El-Khoueiry, A. (Anthony)|||/items/8144acbd-0107-4f48-8776-9e28947910d4, et al. Nivolumab in Sorafenib-naive and Sorafenib-experienced Patients With Advanced Hepatocellular Carcinoma: 5-year Follow-up From CheckMate 040. 2023.